Results 151 to 160 of about 2,408 (176)

Transition from LDL apheresis to evolocumab in heterozygous FH is equally effective in lowering LDL, without lowering HDL cholesterol

Atherosclerosis, 2016
Knut Tore Lappegård, Anders Hovland
exaly  

Reduction of lipoprotein(a) by LDL-apheresis using a dextran sulfate cellulose column in patients with familial hypercholesterolemia

Atherosclerosis, 1993
Junji Koizumi, Y Uno, Akihiro Inazu
exaly  

Long-term reduction of C-reactive protein concentration by regular LDL apheresis

Atherosclerosis, 2004
Klaus Empen, Klaus G Parhofer
exaly  

LDL-apheresis: questions for the future

Transfusion Science, 1999
openaire   +2 more sources

Effects of two whole blood systems (DALI and Liposorber D) for LDL apheresis on lipids and cardiovascular risk markers in severe hypercholesterolemia

Journal of Clinical Apheresis, 2007
Klaus G Parhofer
exaly  

[LDL-apheresis].

Nihon rinsho. Japanese journal of clinical medicine, 2007
Hisashi, Makino, Mariko, Harada-Shiba
openaire   +1 more source

LDL apheresis improves deranged cardiovagal modulation in hypercholesterolemic patients

Atherosclerosis, 2010
Manja Reimann, Ulrich Julius, Sergey Tselmin   +2 more
exaly  

26 Years of LDL – Apheresis: A review of experience

Transfusion and Apheresis Science, 2009
H Borberg
exaly  

LDL apheresis

2011
openaire   +1 more source

Long-term effects of LDL apheresis on carotid arterial atherosclerosis in familial hypercholesterolaemic patients

Journal of Internal Medicine, 1999
Nobuhiko Koga, Tadayuki Hiroki
exaly